<p>FutureHouse, an Eric Schmidt-backed nonprofit that aims to build an &#8220;AI scientist&#8221; within the next decade,&nbsp;has released a new tool that it claims can help support &#8220;data-driven discovery&#8221; in biology. The new tool comes just a week after FutureHouse launched its API and platform. The tool, called Finch, takes in biology data (primarily in the [&hellip;]</p>

<p>NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has raised $130M.</p>

<p>With long waiting lists and rising costs in overburdened healthcare systems, many people are turning to AI-powered chatbots like ChatGPT for medical self-diagnosis. About one in six American adults already use chatbots for health advice at least monthly, according to one recent survey. But placing too much trust in chatbots&#8217; outputs can be risky, in [&hellip;]</p>

<p>Blink and you’ll miss it: A startup out of Finland is taking a new look at the market for prescription eyewear. Tapping into innovations in eye-tracking and liquid crystal lens technology, IXI is building low-power glasses that will invisibly and automatically adjust to account for a wearer&#8217;s presbyopia (far-sightedness). Four years into its life, Helsinki-based [&hellip;]</p>

<p>Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer cases and 9.7 million cancer-related deaths globally in 2022, with projections showing a rise to 29.9 million new cases by 2040. Craif, spun off from Nagoya University in Japan in 2018, is using microRNA [&hellip;]</p>

<p>A startup called Superpower is publicly launching what it calls the world’s first super app that is designed to help people better understand and take care of their health. For $499, the startup offers biannual lab testing that analyzes over 100 blood biomarkers across 21 categories, giving people a more comprehensive look at their health [&hellip;]</p>

<p>Leaders of the House Committee on Energy and Commerce said they are investigating how 23andMe’s bankruptcy might affect customers’ data. Representatives Brett Guthrie, Gus Bilirakis, and Gary Palmer (all Republicans) sent a letter Thursday to the genetic testing company’s interim CEO, Joe Selsavage, asking a number of questions about how 23andMe will handle customer data [&hellip;]</p>

<p>Chapter, a Medicare advisory startup co-founded by former Republican presidential hopeful Vivek Ramaswamy, has closed a $75 million funding round at a valuation of $1.5 billion led by private equity and venture firm Stripes. The startup helps seniors choose Medicare health plans analyzing doctors, hospitals, and prescription drug coverage. Unlike many other Medicare insurance brokers, [&hellip;]</p>

<p>The science fiction trope of humans superpowered by computer and bionic implants is fast becoming a reality, and today, a startup hoping for a role in how that plays out is announcing some funding.&nbsp; Phantom Neuro, which is developing a wristband-like device that gets implanted under the skin to let a person control prosthetic limbs, [&hellip;]</p>

<p>In recent years, focus on career and delayed marriage age is driving some women to consider preserving their fertility through egg freezing. But the steep cost of the procedure, estimated at $10,000 to $15,000 per attempt, means many women can&#8217;t afford it during their most fertile years: 20s and early 30s. Cofertility, a startup founded [&hellip;]</p>

<p>TechCrunch Sessions: AI is fast approaching. So, what does that mean for you? It means exhibit tables are nearly gone — and now’s your chance to grab one before they’re all sold out. If you’ve got a game-changing product to showcase to the AI world, don’t keep it quiet. Exhibit your brand in front of [&hellip;]</p>

<p>It’s been a couple of years since our last topic-focused, one-day event — but with AI transforming the tech landscape, we couldn’t miss the chance to gather 1,200 founders, CEOs, entrepreneurs, investors, and anyone shaping the future of AI for a deep dive into what’s next. On June 5 in Zellerbach Hall at UC Berkeley, [&hellip;]</p>

<p>On Monday, the “de-extinction” startup Colossal Biosciences announced its most ambitious results to date: the dire wolf. These are creatures that have been extinct for more than 12,000 years and made famous by the HBO show &#8220;Game of Thrones.&#8221; These white, fluffy animals live on a 2,000-acre preserve in a location so secretive that journalists, [&hellip;]</p>

<p>Peter Diamandis, a futurist with degrees from both MIT and Harvard, has spent much of the past two decades evangelizing a vision of an abundant future driven by exponential technologies that will lengthen our lives. The serial entrepreneur and founder of organizations like the XPRIZE Foundation and Singularity University has also cultivated close ties with [&hellip;]</p>

<p>Isomorphic Labs, the AI drug-discovery platform that was spun out of Google&#8217;s DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital, with participation from GV and existing investor Alphabet, Google&#8217;s parent, it said.     The funding will accelerate further development of Isomorphic&#8217;s AI drug [&hellip;]</p>

<p>Apple is developing a new version of its Health app that includes an AI coach that can advise users on how to get healthier, according to Bloomberg’s Mark Gurman. Gurman first reported that something like this was in the works back in 2023, but now he says development is moving ahead, with the new features [&hellip;]</p>

<p>Women&#8217;s health and its startups building connected breast pumps, period trackers, and other apps and hardware designed for women have collectively pulled in more than $5 billion in funding in the last five years, but the market is tight, and now, two of the trailblazers in the space are coming together as consolidation beckons.&nbsp; Willow, [&hellip;]</p>

<p>YC-backed startup Taxo has raised a $5m seed round to save doctors time and money on admin work.</p>

<p>The health insurance giant is the latest to remove references to diversity, equity and inclusion policies amid mounting pressure from the Trump administration.</p>

<p>Genetics testing company 23andMe has filed for Chapter 11 bankruptcy protection in the U.S. to initiate the sale of its assets. Alongside the announcement, the company&#8217;s co-founder and CEO, Anne Wojcicki, separately said she is leaving to become an independent bidder for 23andMe. “After a thorough evaluation of strategic alternatives, we have determined that a [&hellip;]</p>